Biotech

All Articles

MBX pursues $136M IPO to take competitor to Ascendis right into period 3

.MBX has actually elaborated strategies to consume over $136 thousand coming from its own IPO as the...

Relay boob cancer records tee up encounter AstraZeneca's Truqap

.Relay Rehabs has actually beaten its survival target in a first-in-human breast cancer research stu...

AZ details AI-enabled TROP2 biomarker approach for Daiichi ADC

.AstraZeneca has actually utilized artificial intelligence to formulate a special biomarker for its ...

AstraZeneca IL-33 drug falls short to strengthen COPD breathing in ph. 2

.AstraZeneca execs state they are "not stressed" that the breakdown of tozorakimab in a phase 2 cons...

BMS vet answers Foghorn's call for CBO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial management hirings, firings an...

Zenas, Bicara set out to put forward $180M-plus in separate IPOs

.After uncovering strategies to hit the U.S. public markets lower than a month ago, Zenas Biopharma ...

Psyence gets fellow psilocybin biotech Clairvoyant

.Psyence Biomedical is paying $500,000 in allotments to get fellow psilocybin-based biotech Clairvoy...

FDA interested Iterum's urinary tract disease medicine could possibly result in antimicrobial protection

.Five months after approving Power Therapeutics' Pivya as the 1st brand-new procedure for straightfo...

Eli Lilly dives deeper into AI with $409M Hereditary Jump deal

.Eli Lilly has sprung into an AI-enabled drug invention bargain, partnering along with RNA expert Ge...

After FDA rejection as well as cutbacks, Lykos chief executive officer is actually leaving

.Lykos chief executive officer and also creator Amy Emerson is actually walking out, with chief work...